OXiGENE Reports First Quarter 2012 Financial Results

May 10, 2012 |

1 min read

SOUTH SAN FRANCISCO, Calif., May 9, 2012 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, reported financial results for the quarter ending March 31, 2012.

Earnings

MORE ON THIS TOPIC

cutting off a row of people into pieces

Layoffs

Editas Axes 60% of Staff, Sickle Cell Therapy After Failing to Find Partner

December 13, 2024

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Bavarian, BenevolentAI, Chroma Medicine and Nvelop Therapeutics Cut Staff

December 12, 2024

·

205 min read

·

BioSpace Editorial Staff

Podcast

Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More

December 11, 2024

·

1 min read

·

Heather McKenzie

Group Of Employees Being Fired By Their Company.

Layoffs

Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline

December 10, 2024

·

2 min read

·